Rheumatoid arthritis patients taking Abbott Laboratories' blockbuster drug Humira or Johnson & Johnson's Remicade face triple the risk of developing several kinds of cancer and double the risk of getting serious infections, a new study found.
BioAdvance Investment Recognizes Potential of Midway's Proprietary Polymer MDY-1001 to Treat Disorders Including Crohn's Disease and Ulcerative Colitis
Qwest Communications said Monday it will buy privately owned OnFiber in a $107 million deal that could help the Denver-based telecom company compete nationally with the giants.
Qwest's reported refusal to give its customer calling records to the National Security Agency is winning the Denver-based phone company big fans online.
On a chilly Tuesday night in late March, reason enough not to brave the cold, officials at the Suffolk Y Jewish Community Center in Commack were stunned when their auditorium overflowed with 700 people.
Qwest Communications is extending its out-of-region reach and revenue with the acquisition of metro Ethernet provider OnFiber Communications for $107 million.
DENVER--(BUSINESS WIRE)--May 15, 2006--Qwest Communications International Inc. (NYSE: Q) announced today that it will acquire privately held OnFiber Communications, Inc., an Austin-based provider of custom-built and managed metropolitan Ethernet and wide-area network solutions.
FEW customers are given to gushing about their phone companies, but before last week's report that Qwest Communications was apparently the lone holdout among the Big Four telecommunications companies secretly supplying the National Security Agency with call records on ordinary Am
NEW YORK, May 15 (Reuters) - Local telephone operator Qwest Communications International Inc. (Q.N: Quote, Profile, Research) said on Monday it agreed to buy privately held communications network operator OnFiber Communications Inc.
Denver-based Qwest Communications has big plans, after announcing a return to profitability Wednesday.
Former Qwest chief executive Joe Nacchio accused prosecutors Monday of misleading grand jurors when the government sought an indictment against him last year.
BRUSSELS (AFX) - Shares were higher midmorning on sentiment boosted by overnight Wall Street gains, with UCB in positive territory as the market downplayed the impact of phase three study results on the pharmaceutical group's Crohn's disease drug Cimzia, which prompted a broker
Schering-Plough Corp. on Thursday said its profit more than tripled in the first quarter behind strong sales of the cholesterol drugs Vytorin and Zetia, and its top-seller, the rheumatoid arthritis drug Remicade. Its shares rose more than 2 percent. ..
DENVER Prosecutors may adjust the sentence for a former Qwest Communications executive, who pleaded guilty to an accessory count in a 34-(m)-million-dollar fraud scheme.
A large pension fund has withdrawn from a $400 million class-action shareholder settlement with Qwest Communications, but it's unclear whether any others will follow suit.
Stem cells to treat Crohn's Disease... I was not aware of this one... they are in a Phase II trial already.
Johnson & Johnson's Remicade drug received priority-review status for treating Crohn's disease in children.
With no new products on the immediate horizon, Centocor Inc. is banking on the expanded use of its flagship product to continue its revenue growth this year.
DENVER (AP)--A federal judge on Thursday dismissed two claims the Securities and Exchange Commission made in its civil fraud lawsuit against former Qwest Communications International Inc.
Qwest Communications International Inc. (Q) (Q) said Thursday that Chairman and Chief Executive Richard C. Notebaert got a $3.15 million bonus for 2005, up from his 2004 bonus of $2.97 million.
Vonage filed to go public nearly two months ago but it has yet to file any amended registration statements with the Securities and Exchange Commission.
DRUG developer Peptech says developing antibodies is the way into the future, even though biotechnology licensing deals are sometimes "like pulling a rabbit out of a hat".
The new website is a website developed by a Crohn's disease patient and victim of serious medical malpractice.
BLOCKBUSTER TO BE? UCB's most exciting new drug is Cimzia. The antibody-based medicine is being targeted initially at people with Crohn's disease, a chronic inflammatory disorder of the digestive tract that affects nearly 1 million patients worldwide. If the U.S.
Thursday afternoon, Schering-Plough Corp. , announced that its drug REMICADE, in combination with methotrexate has been approved in Australia, for the treatment of early rheumatoid
Latest Comments